Details for New Drug Application (NDA): 215316
✉ Email this page to a colleague
The generic ingredient in DAPTOMYCIN is daptomycin. There are ten drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for 215316
Tradename: | DAPTOMYCIN |
Applicant: | Qilu Pharm Hainan |
Ingredient: | daptomycin |
Patents: | 0 |
Suppliers and Packaging for NDA: 215316
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215316 | ANDA | APOTEX CORP. | 60505-6229 | 60505-6229-4 | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6229-4) / 10 mL in 1 VIAL, SINGLE-USE |
DAPTOMYCIN | daptomycin | POWDER;INTRAVENOUS | 215316 | ANDA | Qilu Pharmaceutical Co., Ltd. | 67184-0549 | 67184-0549-1 | 1 VIAL, SINGLE-USE in 1 CARTON (67184-0549-1) / 10 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 500MG/VIAL | ||||
Approval Date: | Aug 24, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription